Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Counterfeit Task Force Continues Work On Wholesaler “Best Practices”

Executive Summary

FDA's Counterfeit Drug Task Force is continuing to gather information from the drug wholesaler industry on "best practices" for reducing the risk of counterfeits in the pharmaceutical supply chain
Advertisement

Related Content

FDA-Approved Drug Wholesaler Inspection Program Recommended By HDMA
FDA Anti-Counterfeiting Focus Should Be Wholesaler Licensing, PDA Says
FDA Anti-Counterfeiting Focus Should Be Wholesaler Licensing, PDA Says
Electronic Drug Tracking Will “Link” With E-Prescribing – FDA’s McClellan
FDA Anti-Counterfeit Technology Policy Head Is Ex-CMS Staffer Rudolf
FDA Anti-Counterfeit Technology Policy Head Is Ex-CMS Staffer Rudolf
FDA Counterfeit Report Seeks “Electronic Pedigree” To Aid Drug Tracking
FDA Counterfeit Report Seeks “Electronic Pedigree” To Aid Drug Tracking
FDA Counterfeit Report Seeks “Electronic Pedigree” To Aid Drug Tracking
Florida Pedigree Enforcement For 30 “Specified” Drugs Begins Sept. 1
Advertisement
UsernamePublicRestriction

Register

PS042565

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel